Thalidomide Analogs in Brazil: Concern About Teratogenesis
It has been more than 50 years since thalidomide was withdrawn from the world market due to its teratogenic potential. However, its widespread use around the world resumed due to its immunomo-dulatory and anti-angiogenic properties. The drug established itself in new therapies, and interest continue...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
Fundação Oswaldo Cruz (FIOCRUZ),
2014-05-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|